Article Details

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Retrieved on: 2021-03-02 14:01:09

Tags for this article:

Click the tags to see associated articles and topics

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update. View article details on hiswai:

Excerpt

Canopy Growth Corporation (“Canopy Growth” or “Company”) (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and ...

Article found on: investingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo